Company Description
Jackson Acquisition Company II is a special purpose acquisition company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is a blank-check issuer rather than an operating company with commercial products or operating revenue from a conventional business line. Its public-company identity is centered on its SPAC structure, its listed securities, its capital structure and its search for an initial business combination.
The company may pursue a business combination in any industry or geographic location. Its stated search focus is on businesses in healthcare services, healthcare technology or other areas of the healthcare industry. That focus defines the target categories described by the company, while the SPAC structure gives it flexibility to evaluate a range of potential transactions within or outside those categories.
Jackson Acquisition Company II is organized as a Cayman Islands registrant and is associated with ordinary shares traded under the symbol JACS on the New York Stock Exchange. The company has also identified itself as an emerging growth company in its regulatory filings. Its disclosure profile is typical of a blank-check issuer: public records center on formation, securities, governance, shareholder matters, exchange-listing compliance and the mechanics that apply before a business combination is completed.
SPAC structure and corporate status
As a SPAC, Jackson Acquisition Company II was created to combine with an existing business rather than to build an operating platform organically. Until an initial business combination is completed, its durable corporate profile is defined by its acquisition purpose, public listing, governing documents, shareholder base and compliance with exchange and securities-law requirements.
The company has disclosed a New York Stock Exchange continued-listing matter involving the minimum public stockholder requirement under Section 802.01B of the NYSE Listed Company Manual. The company stated that the notice had no immediate impact on its securities and described the plan process available under NYSE procedures. This type of disclosure is part of the company’s public-company status record and does not change its stated role as a blank-check company formed to pursue a business combination.
Stock Performance
Jackson Acquisition Co Ii (JACS) stock last traded at $10.63. Over the past 12 months, the stock has gained 3.7%, ranking #1,132 in 52-week price change. At a market capitalization of $314.5M, JACS is classified as a small-cap stock with approximately 29.6M shares outstanding.
JACS Rankings
Latest News
Jackson Acquisition Co Ii has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all JACS news →
SEC Filings
Jackson Acquisition Co Ii has filed 5 recent SEC filings, including 2 Form SCHEDULE 13G/A, 1 Form SCHEDULE 13G, 1 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all JACS SEC filings →
Financial Highlights
operating income reached -$569K, and net income was $9.1M. The company generated -$428K in operating cash flow. With a current ratio of 1.54, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Jackson Acquisition Co Ii (JACS) currently stands at 1.6 thousand shares, up 1.9% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 81%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Jackson Acquisition Co Ii (JACS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.7 days.
JACS Company Profile & Sector Positioning
Jackson Acquisition Co Ii (JACS) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NYSE. In monthly performance, the stock ranks #2,187 among all tracked companies.
Investors comparing JACS often look at related companies in the same sector, including DRUGS MADE IN AMER ACQUISITION (DMAAU), Andretti Acquisition Corp II-A (POLE), Graf Global Corp (GRAF), Archimedes Tech SPAC Partners II Co. (ATII), and Voyager Acquisition Corp (VACH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate JACS's relative position within its industry.